A detailed history of Principal Financial Group Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 240,813 shares of FOLD stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
240,813
Previous 238,076 1.15%
Holding current value
$2.65 Million
Previous $2.8 Million 14.84%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$9.04 - $11.75 $24,742 - $32,159
2,737 Added 1.15%
240,813 $2.39 Million
Q1 2024

Apr 29, 2024

BUY
$11.43 - $14.24 $832,744 - $1.04 Million
72,856 Added 44.1%
238,076 $2.8 Million
Q4 2023

Feb 07, 2024

BUY
$9.97 - $14.52 $274,513 - $399,793
27,534 Added 20.0%
165,220 $2.34 Million
Q3 2023

Nov 02, 2023

BUY
$11.78 - $13.86 $271,517 - $319,459
23,049 Added 20.11%
137,686 $1.67 Million
Q2 2023

Aug 07, 2023

SELL
$10.72 - $13.3 $2,476 - $3,072
-231 Reduced 0.2%
114,637 $1.44 Million
Q1 2023

May 09, 2023

SELL
$10.91 - $13.54 $145,604 - $180,704
-13,346 Reduced 10.41%
114,868 $1.27 Million
Q4 2022

Feb 09, 2023

BUY
$9.89 - $12.7 $554,176 - $711,631
56,034 Added 77.63%
128,214 $1.57 Million
Q3 2022

Nov 09, 2022

SELL
$9.82 - $12.75 $19,905 - $25,844
-2,027 Reduced 2.73%
72,180 $753,000
Q2 2022

Aug 10, 2022

SELL
$6.23 - $11.12 $24,141 - $43,090
-3,875 Reduced 4.96%
74,207 $796,000
Q1 2022

May 09, 2022

BUY
$7.89 - $12.48 $10,525 - $16,648
1,334 Added 1.74%
78,082 $739,000
Q4 2021

Feb 09, 2022

SELL
$9.82 - $12.44 $310,547 - $393,402
-31,624 Reduced 29.18%
76,748 $886,000
Q3 2021

Nov 09, 2021

BUY
$8.74 - $11.84 $53,934 - $73,064
6,171 Added 6.04%
108,372 $1.04 Million
Q2 2021

Aug 10, 2021

SELL
$8.71 - $10.72 $94,581 - $116,408
-10,859 Reduced 9.6%
102,201 $985,000
Q1 2021

May 10, 2021

SELL
$9.2 - $23.86 $57,076 - $148,027
-6,204 Reduced 5.2%
113,060 $1.12 Million
Q4 2020

Feb 08, 2021

BUY
$13.47 - $24.89 $362,275 - $669,416
26,895 Added 29.12%
119,264 $2.75 Million
Q3 2020

Nov 06, 2020

SELL
$12.89 - $15.89 $62,065 - $76,510
-4,815 Reduced 4.95%
92,369 $1.3 Million
Q2 2020

Aug 05, 2020

BUY
$8.86 - $15.69 $224,645 - $397,819
25,355 Added 35.3%
97,184 $1.47 Million
Q1 2020

May 12, 2020

BUY
$6.63 - $11.16 $7,757 - $13,057
1,170 Added 1.66%
71,829 $663,000
Q4 2019

Feb 05, 2020

BUY
$7.48 - $10.75 $4,772 - $6,858
638 Added 0.91%
70,659 $688,000
Q3 2019

Nov 13, 2019

BUY
$8.02 - $13.25 $53,517 - $88,417
6,673 Added 10.53%
70,021 $561,000
Q2 2019

Aug 12, 2019

BUY
$10.96 - $14.4 $99,966 - $131,342
9,121 Added 16.82%
63,348 $791,000
Q1 2019

May 10, 2019

BUY
$10.04 - $13.92 $18,272 - $25,334
1,820 Added 3.47%
54,227 $738,000
Q4 2018

Feb 14, 2019

SELL
$8.38 - $13.44 $897,447 - $1.44 Million
-107,094 Reduced 67.14%
52,407 $502,000
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $125,303 - $178,665
10,802 Added 7.26%
159,501 $1.93 Million
Q2 2018

Aug 13, 2018

BUY
$13.13 - $17.09 $184,489 - $240,131
14,051 Added 10.44%
148,699 $0
Q1 2018

May 14, 2018

BUY
$13.76 - $17.12 $124,211 - $154,542
9,027 Added 7.19%
134,648 $2.03 Million
Q4 2017

Feb 13, 2018

BUY
$12.51 - $16.24 $1.29 Million - $1.68 Million
103,351 Added 464.08%
125,621 $1.81 Million
Q3 2017

Nov 02, 2017

BUY
$11.74 - $15.78 $261,449 - $351,420
22,270
22,270 $336,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.09B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.